https://scholars.lib.ntu.edu.tw/handle/123456789/535427
標題: | Mucormycosis: Its contemporary face and management strategies | 作者: | HSIN-YUN SUN Singh N. |
公開日期: | 2011 | 卷: | 11 | 期: | 4 | 起(迄)頁: | 301-311 | 來源出版物: | The Lancet Infectious Diseases | 摘要: | Several countries have seen rising frequencies of mucormycosis among patients with haematological disorders, malignancies, or diabetes mellitus, and among transplant recipients. Growing numbers of immunocompromised hosts, widespread use of antifungal agents inactive against mucormycosis, or other unidentified factors, could be contributing to this situation. The predominant clinical manifestations of mucormycosis vary from host to host. Additionally, risk factors specific to different subgroups have been identified, such as leukaemia, allogeneic haemopoietic stem-cell transplant, voriconazole prophylaxis, diabetes, and malnutrition. We summarise the current state of knowledge of characteristics and risk factors and discuss topical developments in therapeutic methods and strategies in the management of mucormycosis. © 2011 Elsevier Ltd. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953042845&doi=10.1016%2fS1473-3099%2810%2970316-9&partnerID=40&md5=455ac1aaaf3ab2d57484bf9dff62bcf2 https://scholars.lib.ntu.edu.tw/handle/123456789/535427 |
ISSN: | 1473-3099 | DOI: | 10.1016/S1473-3099(10)70316-9 | SDG/關鍵字: | amphotericin B; amphotericin B lipid complex; calcineurin inhibitor; colistin; deferasirox; echinocandin; gamma interferon; granulocyte macrophage colony stimulating factor; hydroxymethylglutaryl coenzyme A reductase inhibitor; mammalian target of rapamycin; posaconazole; triazole derivative; voriconazole; allogeneic hematopoietic stem cell transplantation; clinical feature; diabetes mellitus; granulocyte transfusion; human; hyperbaric oxygen; infection prevention; leukemia; malnutrition; mucormycosis; priority journal; review; risk factor; Humans; Immunocompromised Host; Incidence; Mucormycosis; Risk Factors |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。